Now showing items 1-3 of 3

    • Computational Pathology to Discriminate Benign from Malignant Intraductal Proliferations of the Breast 

      Dong, Fei; Irshad, Humayun; Oh, Eun-Yeong; Lerwill, Melinda F.; Brachtel, Elena F.; Jones, Nicholas C.; Knoblauch, Nicholas W.; Montaser-Kouhsari, Laleh; Johnson, Nicole B.; Rao, Luigi K. F.; Faulkner-Jones, Beverly; Wilbur, David C.; Schnitt, Stuart J.; Beck, Andrew H. (Public Library of Science, 2014)
      The categorization of intraductal proliferative lesions of the breast based on routine light microscopic examination of histopathologic sections is in many cases challenging, even for experienced pathologists. The development ...
    • Detection of ERBB2 Amplification in Uterine Serous Carcinoma by Next-Generation Sequencing: An Approach Highly Concordant With Standard Assays 

      Robinson, Carrie; Harrison, Beth; Ligon, Azra; Dong, Fei; Maffeis, Valeria; Matulonis, Ursula; Nucci, Marisa; Kolin, David L. (Springer Science and Business Media LLC, 2020-10-19)
      Uterine serous carcinoma is an aggressive subtype of endometrial cancer that accounts for fewer than 10% of endometrial carcinomas but is responsible for about half of deaths. A subset of cases has HER2 overexpression ...
    • GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas 

      Ritterhouse, Lauren; Vivero, Marina; Mino-Kenudson, Mari; Sholl, Lynette; Iafrate, Anthony; Nardi, Valentina; Dong, Fei (Springer Science and Business Media LLC, 2017-08-04)
      GNAS mutations have been described in mucinous and non-mucinous epithelial neoplasms of the appendix, pancreas, and colon, with hotspot GNAS mutations found in up to two-thirds of pancreatic intraductal papillary mucinous ...